DPP-4 inhibitors × glycemic control

TrialDiabetes, obesity & metabolism2013

Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring.

Y L He et al.PubMed ↗Publisher ↗

What the trial testedas reported · 24 people · 2013

No range given

Reported higher glycemic control, no range given

+21.0percentage points

As reported

difference 21 %, no interval

One number in the abstract

the abstract, start to end

the levels of insulin and C-peptide by 21% (p = 0.012) and 12%

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
21
DPP-4 inhibitorsSulfonylureas & glinidesGlycemic control
1 / 3

11 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 23782529